Types of Tubes
Administration
Interactions
Bioavailability
Drug Considerations
100

This type of enteral tube enters through the mouth and ends in the stomach and is considered an option for short term use

What is Orogastric?

100

____-bore tubes are commonly used for EN feedings and medication administration and are generally more comfortable for patients

What is small?
100

Current enteral nutrition formulas have been reformulated to contain much lower amounts of this vitamin to help reduce the risk of interaction with warfarin

What is vitamin K?
100

This term refers to the proportion of a drug dose that reaches systemic circulation and depends on the fraction of drug absorbed from the gut, the fraction removed by efflux transporters, and/or enzymatic metabolism at the gut mucosa

What is bioavailability?

100

The primary site of action for drugs such as sucralfate and antacids is in this organ and provide little value when administered via small bowel tubes

What is the stomach?

200

This type of enteral tube enters the body from the lower abdomen and ends in the jejunum

What is jejunostomy?

200

This type of enteral tube access is generally preferred for medication administration

What is gastric?
200

When administered concurrently with enteral nutrition, phenytoin's absorption may be ______ by up to 70%

What is reduced?

200

This term refers the ability of a drug molecule to cross the apical membrane of the enterocyte and depends on drug specific factors such as particle size, solubility, and lipophilicity

What is absorption?

200

This DOAC can be given via G-tube but not via J-tube

What is rivaroxaban?

300

This type of tube access is preferred for patients with pancreatitis, gastroparesis, severe GERD, or with increased aspiration risk

What is small bowel (jejunal)?

300

This type of medication formulation is preferred for enteral tube administration as long as it is tolerable

What is liquid?

300

This should be interrupted or held to allow for medication administration via enteral tubes to prevent interactions with the medication

What is enteral nutrition?

300

These two properties are determinants of drug bioavailability 

What are solubility and permeability?

300

This fluoroquinolone's suspension formulation should not be given via feeding tube because it may adhere to the tube and cause tube occlusion

What is ciprofloxacin?

400

Three types of enteral tubes that can enter through the nasal passages

What are nasogastric, nasoduodenal, or nasojejunal?

400

This should be done to an enteral tube that is being used for gastric suctioning prior to and for at least 30 minutes after medication administration

What is clamping?

400

This medication for parkinson's disease should be separated from EN or protein administration by at least 2 hours

What is carbidopa-levodopa

400

This term refers to a medications ability to dissolve in solution and is determined by many factors including melting point, lipophilicity, drug shape, gut pH, and gut motility

What is solubility?

400

This medication can be used as an alternative for tamsulosin to allow for enteral tube administration

What is silodosin?

500

This type of feeding strategy closely mimics a normal eating pattern and is commonly used with tube access that ends in the stomach, however, is not generally tolerated in patients with small bowel tubes

What is bolus feeding?

500

This should be done between administrations of medications via enteral tubes to prevent medication interaction and reduce the risk of tube occlusion

What is water flushes (5-10 mL)?

500

This drug vehicle can be used to prevent drug degradation from stomach acid for acid liable medications or can be used to activate medications that require an alkaline pH 

What is sodium bicarbonate?

500

This term describes the fraction of a drug absorbed across the apical membrane of the gut epithelium and is determined by many factors such as the drug's affinity for transporters, the partition coefficient, and the thickness of the gut's membrane

What is permeability?

500

This class of medications commonly are formulated as enteric coated tablets or delayed-release capsules because they are acid liable (inactivated by gastric acid), which presents extra challenges when administering them via gastric tubes. Additionally, their suspension formulations are high risk for causing tube occlusions

What are proton-pump inhibitors?